Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Thalidomide in Resected Recurrent Colorectal Cancer
NCT00019747Phase 2Terminated
- Sponsor
- National Institutes of Health
- Start
- Aug 1999
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in colorectal cancer (CRC), sponsored by National Institutes of Health. Started Aug 1999; status: terminated.
02
Drugs
thalidomide
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00019747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00019747.